Interestingly, these results resemble the difference in mOS of 6.1 and 14.1 months that Hermann et al from the SARAH trial group demonstrated after stratification according to absorbed tumor dose lesser or greater than 100 Gy in Tc-99m-macroaggregated albumin SPECT/CT-based dosimetry [27]. Here, ALB is linked to neoplasm.